Member Info for OAPK20

As at 22/9/22 CIZ had sufficient funding for about 18 months (Date of Prospectus) which takes us up to 21/3/24 approx. See page 6 of the prospectus.

12/6/23 they raised £350,000 and extended the E3Fund SP facility for £500,000 to 8 December 2024 at a higher fixed price of 2.1p.

Equating to 23,809,524 new Ordinary Shares Or 6.5% shares in issue.

Is it enough funding for the momentum needed to get this to market as things stand ? (Not including the CDT shares available for CIZ to sell currently at $2.70 far lower than the $10 issue price)

Will there be a drawdown on the E3 Fund SP facility end of March or April ? Will it be one full drawdown or in tranches of £100,000 ?

If it is in £100,000 tranches or 4,761,905 shares it is below the 3% TR1 threshold.

Tech- what’s your thoughts ⬇️

No view. Will be looking to see if there’s a particular repetitive posting style, for example COPL, and form a view then. Those involved with COPL articles/Tweets were short COPL fwiw.

Basic practice. Open long or short position. Tip that position in the subscribed for tip rags. Start closing positions. Release SP article, positive or negative depending whether long or short. Finish closing positions into volume. Leave the rag subscribers holding the bag. Rag subscribers hit the BB’s with positive or negative posts depending on which position Rag publishers tip them to take while desperately trying to pass the Rag publisher’s bag onto someone else.

Check BB’s against the SP articles then make up your own mind about posters and motives.

Open short or go long before SP article.

From Bio-Techne

“ “Customers prefer Jess because it has higher throughput than western blot. Furthermore, Jess is faster and more reliable in terms of quantification and allows us to use low sample volumes, for example, difficult-to-obtain samples such as derived neurons of iPSC.”

Looking good for CIZ1b biomarker.

Thanks much appreciated

Neil thanks for posting. Can you provide a link to the quote please.

Anyone going on a professional basis?

Thanks again

Neil thanks for taking the time to reply. Appreciated. Need to do some more digging

Tech - I’m not entirely convinced yet regarding the type and progress of the patent application. The fast track 12 months timescale suggests end of March if you take it from the application date but will be August at least if it’s from publication.

If CIZ haven’t paid for the faster application process (given how tight they are with RNS’s) then it’s a longer process.

My own view is CIZ may want to wait until the patent is granted before commercial launch.

It’s whether they actually have the product ready for launch that’s the main question.

Neilin

Are you confident the patent grant will be announced by the end of March (if it’s a priority application) or do you think it’ll be nearer September/October at the earliest?

When the fun stops. Stop

BeGambleAwareInvesting…

begambleaware.org

Jace - Don’t give them ideas !!!! 😬

Jace86

Posts: 3,289

Price: 2.30

No Opinion

RE: Wallet22 Feb 2024 21:18

I maxed my ISA. I'm surprised the ISA limit hasn't been dropped yet.

Seems the granting of CIZ’s patent could be the catalyst for news flow here.

Applied for 23/3/23 published August 2023. If it’s 12 months from application then end of March onwards could be a last chance to get sub 3p here.

If it takes the longer patent timeline 22-36 months then it’s going to be a long time sitting on hands.

Neil thanks. Re read your post. Is the patent application definitely Priority. If so I believe 6-12 months is suggested application to grant for priority applications.

That would mean grant of patent end of March if the 12 months is from 23/3/23 filing date?

If it’s not priority then 22 months earliest.

Granting of the patent would be timely before commercial launch and Options/Warrant expiry dates.

Stupid question but can the patent be issued without a commercially available LDT or will it coincide with confirmation the LDT test has received regulatory approvals for commercialisation?

Don’t drop that wallet Tech in case it hits you on the back of the head 😁

Couple of points jump out. Are they just catch all paragraphs inserted into the Patrnt filing or is there more to it?

“ The present invention also provides an anticancer drug for use in treating cancer wherein the subject has been identified as having cancer by the method of the invention.

The present invention further provides an anticancer lung cancer drug for use in treating lung cancer wherein the subject has been identified as having lung cancer by the method of the invention.”

Has the use of retrospective testing data been enough for UKCA, CE marking approval, LDT accreditation or FDA 510k clearance or is a prospective study required at further expense to CIZ.

Anything on CIZ patents ?

Be interested in Widglides Bear case and whether they have a Bull case.